Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Zimmer Biomet Holdings, Inc.

NYSE: ZBH · Industrial Applications and Services · 3 alerts · CIK 1136869

Share price
$101.41Close, Nov 16
Market cap
$19.2B
Shares outstanding
189.25MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Orthopedic, Prosthetic & Surgical Appliances & SuppliesSIC 3842

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Zimmer Biomet Holdings, Inc. filings on SEC EDGAR ↗

4:07 PM ET 10-Q
Financial Results

Zimmer Biomet Holdings Q3 2026 Results: Net Income $192M, Down 17.0% YoY

For the nine months ended September 30, 2026, Zimmer Biomet reported net sales of $6,326.6 million, a 5.7% increase over the prior year, and net earnings of $630.9 million. The company experienced higher selling, general, and administrative expenses but saw an improvement in operating profit from $943.6 million to $1,006.8 million year-over-year.

Key figure
Net income $192M · -17.0% YoY
6:31 AM ET 8-K
Financial Results

Zimmer Biomet Holdings Financial Results

Zimmer Biomet reported Q3 2026 net sales of $2.063 billion, a 3.1% increase over the prior year, driven by strong performance in its Hips, S.E.T., and Technology & Data franchises. The company updated its full-year 2026 guidance, raising its organic constant-currency sales growth and adjusted EPS targets based on solid commercial execution.

Term
Q3 2026

“We are very pleased with our solid third quarter results, growing net sales 3.7% on a constant-currency basis and generating strong operating and free cash flow. Our Hips, S.E.T. and Technology & Data, Bone Cement and Surgical franchises – representing two-thirds of our book of business – grew at upper single digit or double-digit rates, validating the progress of our diversification strategy, the strength of our innovation engine and the significant strides we are making in commercial execution.”

Ivan Tornos, Chairman, President and CEO of Zimmer Biomet

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.